Page 2 - Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 26, 2024

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

86 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RAD

Radiopharm Theranostics
AU$0.03119.2%-56.3%AU$67.4mn/aPS34.4xE10.9%n/a

PAR

Paradigm Biopharmaceuticals
AU$0.57105.4%45.6%AU$201.5mn/aPB8.5xE8.8%n/a

ILA

Island Pharmaceuticals
AU$0.2130.3%194.5%AU$33.5mn/aPS26.8xE4.1%n/a

RAC

Race Oncology
AU$1.424.0%55.5%AU$241.2mAU$3.67PS60.3xE0.1%n/a

ATH

Alterity Therapeutics
AU$0.0030%-25.0%AU$16.0mn/aPS4xE-2.7%n/a

NEU

Neuren Pharmaceuticals
AU$12.37-9.6%-17.8%AU$1.6bAU$26.21PE13.5xE-9.9%n/a

ACW

Actinogen Medical
AU$0.0250%8.7%AU$73.6mn/aPS7.4xE-22.1%n/a

MDC

Medlab Clinical
AU$6.600%-43.6%AU$15.1mn/aPS9.8xE-44.7%n/a

RCE

Recce Pharmaceuticals
AU$0.460%3.4%AU$106.7mAU$2.46PS21.2xE-51.3%n/a

EPN

Epsilon Healthcare
AU$0.0240%20.0%AU$7.2mn/aPB0.8xn/an/a

AGN

Argenica Therapeutics
AU$0.67-5.0%60.2%AU$85.2mn/aPS32.8xn/an/a

1AD

AdAlta
AU$0.018-5.3%-18.2%AU$10.9mn/aPS6.3xn/an/a

ALA

Arovella Therapeutics
AU$0.18-2.7%95.7%AU$190.0mn/aPS97.3xn/an/a

NYR

Nyrada
AU$0.105.0%400.0%AU$22.0mn/aPS6.8xn/an/a

1AI

Algorae Pharmaceuticals
AU$0.006-14.3%-53.8%AU$10.1mn/aPS80.9xn/an/a

CAN

Cann Group
AU$0.045-2.2%-57.1%AU$21.1mn/aPS1.1xn/an/a

BOD

Bod Science
AU$0.0240%-65.2%AU$4.3mn/aPS1.3xn/an/a

CGB

Cann Global
AU$0.0210%-72.0%AU$5.4mn/aPS9.7xn/an/a

NC6

Nanollose
AU$0.0170%-15.0%AU$2.9mn/aPS9.6xn/an/a

HXL

Hexima
AU$0.0130%n/aAU$2.2mn/aPS35.2xn/an/a

IXC

Invex Therapeutics
AU$0.067-11.8%-70.9%AU$5.0mn/aPS4.2xn/a278.1%

DXB

Dimerix
AU$0.340%148.1%AU$186.9mn/aPS320.3xn/an/a

BIT

Biotron
AU$0.02110.5%-78.1%AU$19.0mn/aPS11.5xn/an/a

BP8

BPH Global
AU$0.00460.0%-60.0%AU$1.6mn/aPS14.4xn/an/a
Page 2 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.